Report Detail
Global Intradermal Injection Device Market Insights, Forecast to 2028
- RnM4431768 |
- 06 May, 2022 |
- Global |
- 91 Pages |
- QYResearch |
- Medical Devices & Consumables
Summary:
Market Analysis and Insights: Global Intradermal Injection Device Market
The process of intradermal injection employs micron-sized needles that are inserted 1.5mm perpendicularly into the skin, and which inject approximately 100-200μl of a liquid vaccine formulation into the dermal skin layers.
Due to the COVID-19 pandemic, the global Intradermal Injection Device market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Disposable accounting for % of the Intradermal Injection Device global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Intradermal Injection Device market size is valued at US$ million in 2021, while the US and Europe Intradermal Injection Device are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Intradermal Injection Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Intradermal Injection Device include NanoPass Technologies, Lightnix Inc, Idevax, BD, Debiotech SA, PharmaJet, Novosanis, HIPRA and Terumo. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
Segment by Type
Disposable
Reusable
Segment by Application
Hospital
Clinic
Others
Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Intradermal Injection Device market back to the pre-covid levels.
Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Outlook
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
NanoPass Technologies
Lightnix Inc
Idevax
BD
Debiotech SA
PharmaJet
Novosanis
HIPRA
Terumo
Frequently Asked Questions
Which is the most lucrative product segment in the Intradermal Injection Device market?
Which are the prominent strategies of the Intradermal Injection Device market players?
Which factors are increasing the competition in the Intradermal Injection Device market?
Which are the recommendations provided by the Intradermal Injection Device industry experts?
Which region will witness rewarding growth during the forecast period?
What factors will curb the Intradermal Injection Device market growth?
Which product segment will register the fastest growth rate in the Intradermal Injection Device market?
Which emerging trends will impact the Intradermal Injection Device market growth?
Which are the high-impact rendering factors in the Intradermal Injection Device market?
Which companies will maintain their lead on the Intradermal Injection Device market?
Table of Contents
1 Study Coverage
- 1.1 Intradermal Injection Device Product Introduction
- 1.2 Market by Type
- 1.2.1 Global Intradermal Injection Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Disposable
- 1.2.3 Reusable
- 1.3 Market by Application
- 1.3.1 Global Intradermal Injection Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Executive Summary
- 2.1 Global Intradermal Injection Device Sales Estimates and Forecasts 2017-2028
- 2.2 Global Intradermal Injection Device Revenue Estimates and Forecasts 2017-2028
- 2.3 Global Intradermal Injection Device Revenue by Region: 2017 VS 2021 VS 2028
- 2.4 Global Intradermal Injection Device Sales by Region
- 2.4.1 Global Intradermal Injection Device Sales by Region (2017-2022)
- 2.4.2 Global Sales Intradermal Injection Device by Region (2023-2028)
- 2.5 Global Intradermal Injection Device Revenue by Region
- 2.5.1 Global Intradermal Injection Device Revenue by Region (2017-2022)
- 2.5.2 Global Intradermal Injection Device Revenue by Region (2023-2028)
- 2.6 North America
- 2.7 Europe
- 2.8 Asia-Pacific
- 2.9 Latin America
- 2.10 Middle East & Africa
3 Competition by Manufacturers
- 3.1 Global Intradermal Injection Device Sales by Manufacturers
- 3.1.1 Global Top Intradermal Injection Device Manufacturers by Sales (2017-2022)
- 3.1.2 Global Intradermal Injection Device Sales Market Share by Manufacturers (2017-2022)
- 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intradermal Injection Device in 2021
- 3.2 Global Intradermal Injection Device Revenue by Manufacturers
- 3.2.1 Global Intradermal Injection Device Revenue by Manufacturers (2017-2022)
- 3.2.2 Global Intradermal Injection Device Revenue Market Share by Manufacturers (2017-2022)
- 3.2.3 Global Top 10 and Top 5 Companies by Intradermal Injection Device Revenue in 2021
- 3.3 Global Intradermal Injection Device Sales Price by Manufacturers (2017-2022)
- 3.4 Analysis of Competitive Landscape
- 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Intradermal Injection Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4.3 Global Intradermal Injection Device Manufacturers Geographical Distribution
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Global Intradermal Injection Device Sales by Type
- 4.1.1 Global Intradermal Injection Device Historical Sales by Type (2017-2022)
- 4.1.2 Global Intradermal Injection Device Forecasted Sales by Type (2023-2028)
- 4.1.3 Global Intradermal Injection Device Sales Market Share by Type (2017-2028)
- 4.2 Global Intradermal Injection Device Revenue by Type
- 4.2.1 Global Intradermal Injection Device Historical Revenue by Type (2017-2022)
- 4.2.2 Global Intradermal Injection Device Forecasted Revenue by Type (2023-2028)
- 4.2.3 Global Intradermal Injection Device Revenue Market Share by Type (2017-2028)
- 4.3 Global Intradermal Injection Device Price by Type
- 4.3.1 Global Intradermal Injection Device Price by Type (2017-2022)
- 4.3.2 Global Intradermal Injection Device Price Forecast by Type (2023-2028)
5 Market Size by Application
- 5.1 Global Intradermal Injection Device Sales by Application
- 5.1.1 Global Intradermal Injection Device Historical Sales by Application (2017-2022)
- 5.1.2 Global Intradermal Injection Device Forecasted Sales by Application (2023-2028)
- 5.1.3 Global Intradermal Injection Device Sales Market Share by Application (2017-2028)
- 5.2 Global Intradermal Injection Device Revenue by Application
- 5.2.1 Global Intradermal Injection Device Historical Revenue by Application (2017-2022)
- 5.2.2 Global Intradermal Injection Device Forecasted Revenue by Application (2023-2028)
- 5.2.3 Global Intradermal Injection Device Revenue Market Share by Application (2017-2028)
- 5.3 Global Intradermal Injection Device Price by Application
- 5.3.1 Global Intradermal Injection Device Price by Application (2017-2022)
- 5.3.2 Global Intradermal Injection Device Price Forecast by Application (2023-2028)
6 North America
- 6.1 North America Intradermal Injection Device Market Size by Type
- 6.1.1 North America Intradermal Injection Device Sales by Type (2017-2028)
- 6.1.2 North America Intradermal Injection Device Revenue by Type (2017-2028)
- 6.2 North America Intradermal Injection Device Market Size by Application
- 6.2.1 North America Intradermal Injection Device Sales by Application (2017-2028)
- 6.2.2 North America Intradermal Injection Device Revenue by Application (2017-2028)
- 6.3 North America Intradermal Injection Device Market Size by Country
- 6.3.1 North America Intradermal Injection Device Sales by Country (2017-2028)
- 6.3.2 North America Intradermal Injection Device Revenue by Country (2017-2028)
- 6.3.3 United States
- 6.3.4 Canada
7 Europe
- 7.1 Europe Intradermal Injection Device Market Size by Type
- 7.1.1 Europe Intradermal Injection Device Sales by Type (2017-2028)
- 7.1.2 Europe Intradermal Injection Device Revenue by Type (2017-2028)
- 7.2 Europe Intradermal Injection Device Market Size by Application
- 7.2.1 Europe Intradermal Injection Device Sales by Application (2017-2028)
- 7.2.2 Europe Intradermal Injection Device Revenue by Application (2017-2028)
- 7.3 Europe Intradermal Injection Device Market Size by Country
- 7.3.1 Europe Intradermal Injection Device Sales by Country (2017-2028)
- 7.3.2 Europe Intradermal Injection Device Revenue by Country (2017-2028)
- 7.3.3 Germany
- 7.3.4 France
- 7.3.5 U.K.
- 7.3.6 Italy
- 7.3.7 Russia
8 Asia Pacific
- 8.1 Asia Pacific Intradermal Injection Device Market Size by Type
- 8.1.1 Asia Pacific Intradermal Injection Device Sales by Type (2017-2028)
- 8.1.2 Asia Pacific Intradermal Injection Device Revenue by Type (2017-2028)
- 8.2 Asia Pacific Intradermal Injection Device Market Size by Application
- 8.2.1 Asia Pacific Intradermal Injection Device Sales by Application (2017-2028)
- 8.2.2 Asia Pacific Intradermal Injection Device Revenue by Application (2017-2028)
- 8.3 Asia Pacific Intradermal Injection Device Market Size by Region
- 8.3.1 Asia Pacific Intradermal Injection Device Sales by Region (2017-2028)
- 8.3.2 Asia Pacific Intradermal Injection Device Revenue by Region (2017-2028)
- 8.3.3 China
- 8.3.4 Japan
- 8.3.5 South Korea
- 8.3.6 India
- 8.3.7 Australia
- 8.3.8 China Taiwan
- 8.3.9 Indonesia
- 8.3.10 Thailand
- 8.3.11 Malaysia
9 Latin America
- 9.1 Latin America Intradermal Injection Device Market Size by Type
- 9.1.1 Latin America Intradermal Injection Device Sales by Type (2017-2028)
- 9.1.2 Latin America Intradermal Injection Device Revenue by Type (2017-2028)
- 9.2 Latin America Intradermal Injection Device Market Size by Application
- 9.2.1 Latin America Intradermal Injection Device Sales by Application (2017-2028)
- 9.2.2 Latin America Intradermal Injection Device Revenue by Application (2017-2028)
- 9.3 Latin America Intradermal Injection Device Market Size by Country
- 9.3.1 Latin America Intradermal Injection Device Sales by Country (2017-2028)
- 9.3.2 Latin America Intradermal Injection Device Revenue by Country (2017-2028)
- 9.3.3 Mexico
- 9.3.4 Brazil
- 9.3.5 Argentina
10 Middle East and Africa
- 10.1 Middle East and Africa Intradermal Injection Device Market Size by Type
- 10.1.1 Middle East and Africa Intradermal Injection Device Sales by Type (2017-2028)
- 10.1.2 Middle East and Africa Intradermal Injection Device Revenue by Type (2017-2028)
- 10.2 Middle East and Africa Intradermal Injection Device Market Size by Application
- 10.2.1 Middle East and Africa Intradermal Injection Device Sales by Application (2017-2028)
- 10.2.2 Middle East and Africa Intradermal Injection Device Revenue by Application (2017-2028)
- 10.3 Middle East and Africa Intradermal Injection Device Market Size by Country
- 10.3.1 Middle East and Africa Intradermal Injection Device Sales by Country (2017-2028)
- 10.3.2 Middle East and Africa Intradermal Injection Device Revenue by Country (2017-2028)
- 10.3.3 Turkey
- 10.3.4 Saudi Arabia
11 Company Profiles
- 11.1 NanoPass Technologies
- 11.1.1 NanoPass Technologies Corporation Information
- 11.1.2 NanoPass Technologies Overview
- 11.1.3 NanoPass Technologies Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.1.4 NanoPass Technologies Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
- 11.1.5 NanoPass Technologies Recent Developments
- 11.2 Lightnix Inc
- 11.2.1 Lightnix Inc Corporation Information
- 11.2.2 Lightnix Inc Overview
- 11.2.3 Lightnix Inc Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.2.4 Lightnix Inc Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
- 11.2.5 Lightnix Inc Recent Developments
- 11.3 Idevax
- 11.3.1 Idevax Corporation Information
- 11.3.2 Idevax Overview
- 11.3.3 Idevax Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.3.4 Idevax Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
- 11.3.5 Idevax Recent Developments
- 11.4 BD
- 11.4.1 BD Corporation Information
- 11.4.2 BD Overview
- 11.4.3 BD Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.4.4 BD Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
- 11.4.5 BD Recent Developments
- 11.5 Debiotech SA
- 11.5.1 Debiotech SA Corporation Information
- 11.5.2 Debiotech SA Overview
- 11.5.3 Debiotech SA Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.5.4 Debiotech SA Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
- 11.5.5 Debiotech SA Recent Developments
- 11.6 PharmaJet
- 11.6.1 PharmaJet Corporation Information
- 11.6.2 PharmaJet Overview
- 11.6.3 PharmaJet Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.6.4 PharmaJet Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
- 11.6.5 PharmaJet Recent Developments
- 11.7 Novosanis
- 11.7.1 Novosanis Corporation Information
- 11.7.2 Novosanis Overview
- 11.7.3 Novosanis Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.7.4 Novosanis Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
- 11.7.5 Novosanis Recent Developments
- 11.8 HIPRA
- 11.8.1 HIPRA Corporation Information
- 11.8.2 HIPRA Overview
- 11.8.3 HIPRA Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.8.4 HIPRA Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
- 11.8.5 HIPRA Recent Developments
- 11.9 Terumo
- 11.9.1 Terumo Corporation Information
- 11.9.2 Terumo Overview
- 11.9.3 Terumo Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.9.4 Terumo Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
- 11.9.5 Terumo Recent Developments
12 Industry Chain and Sales Channels Analysis
- 12.1 Intradermal Injection Device Industry Chain Analysis
- 12.2 Intradermal Injection Device Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
- 12.3 Intradermal Injection Device Production Mode & Process
- 12.4 Intradermal Injection Device Sales and Marketing
- 12.4.1 Intradermal Injection Device Sales Channels
- 12.4.2 Intradermal Injection Device Distributors
- 12.5 Intradermal Injection Device Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
- 13.1 Intradermal Injection Device Industry Trends
- 13.2 Intradermal Injection Device Market Drivers
- 13.3 Intradermal Injection Device Market Challenges
- 13.4 Intradermal Injection Device Market Restraints
14 Key Findings in The Global Intradermal Injection Device Study
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Author Details
Summary:
Get latest Market Research Reports on Intradermal Injection Device. Industry analysis & Market Report on Intradermal Injection Device is a syndicated market report, published as Global Intradermal Injection Device Market Insights, Forecast to 2028. It is complete Research Study and Industry Analysis of Intradermal Injection Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
